CGX-208

N/A

Report date: 2025/01/26 18:14:57

Base Information

Drug NameCGX-208
Drug Alias Nameanti-misfolded alpha-synuclein scFv (Cognyxx Pharmaceuticals)CGX-208
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionSynuclein alpha inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCognyxx Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesCognyxx Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A